Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 887.5 Million CNY | -11.95% |
| 2022 | 1 Billion CNY | 33.24% |
| 2021 | 756.45 Million CNY | -1.79% |
| 2020 | 770.27 Million CNY | -13.9% |
| 2019 | 894.59 Million CNY | 69.51% |
| 2018 | 527.74 Million CNY | -6.65% |
| 2017 | 565.33 Million CNY | -0.39% |
| 2016 | 567.56 Million CNY | 47.43% |
| 2015 | 384.97 Million CNY | 50.62% |
| 2014 | 255.59 Million CNY | 39.35% |
| 2013 | 183.42 Million CNY | 654.66% |
| 2012 | 24.3 Million CNY | -23.02% |
| 2011 | 31.57 Million CNY | 10.85% |
| 2010 | 28.48 Million CNY | -53.01% |
| 2009 | 60.61 Million CNY | 14.26% |
| 2008 | 53.04 Million CNY | -41.21% |
| 2007 | 90.22 Million CNY | -14.22% |
| 2006 | 105.18 Million CNY | -4.09% |
| 2005 | 109.67 Million CNY | -40.71% |
| 2004 | 184.98 Million CNY | 32.17% |
| 2003 | 139.95 Million CNY | -2.39% |
| 2002 | 143.37 Million CNY | -8.76% |
| 2001 | 157.14 Million CNY | -7.0% |
| 2000 | 168.97 Million CNY | 13.06% |
| 1999 | 149.45 Million CNY | -61.11% |
| 1998 | 384.28 Million CNY | 80.69% |
| 1997 | 212.67 Million CNY | 26.19% |
| 1996 | 168.53 Million CNY | -0.56% |
| 1995 | 169.48 Million CNY | 7.14% |
| 1994 | 158.18 Million CNY | 51.64% |
| 1993 | 104.31 Million CNY | 23.97% |
| 1992 | 84.14 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 876.63 Million CNY | -1.22% |
| 2024 Q2 | 767.08 Million CNY | -12.5% |
| 2024 Q3 | 788.59 Million CNY | 2.8% |
| 2023 Q3 | 820.76 Million CNY | -8.84% |
| 2023 FY | 887.5 Million CNY | -11.95% |
| 2023 Q4 | 887.5 Million CNY | 8.13% |
| 2023 Q1 | 777.16 Million CNY | -22.89% |
| 2023 Q2 | 900.37 Million CNY | 15.85% |
| 2022 Q4 | 1 Billion CNY | 20.68% |
| 2022 Q3 | 835.17 Million CNY | 5.8% |
| 2022 Q2 | 789.36 Million CNY | -1.63% |
| 2022 FY | 1 Billion CNY | 33.24% |
| 2022 Q1 | 802.47 Million CNY | 6.08% |
| 2021 FY | 756.45 Million CNY | -1.79% |
| 2021 Q1 | 820.14 Million CNY | 6.47% |
| 2021 Q2 | 744.57 Million CNY | -9.21% |
| 2021 Q3 | 781.8 Million CNY | 5.0% |
| 2021 Q4 | 756.45 Million CNY | -3.24% |
| 2020 Q4 | 770.27 Million CNY | -4.98% |
| 2020 FY | 770.27 Million CNY | -13.9% |
| 2020 Q3 | 810.65 Million CNY | 1.11% |
| 2020 Q2 | 801.71 Million CNY | -14.65% |
| 2020 Q1 | 939.36 Million CNY | 5.0% |
| 2019 FY | 894.59 Million CNY | 69.51% |
| 2019 Q1 | 667.23 Million CNY | 26.43% |
| 2019 Q2 | 780.58 Million CNY | 16.99% |
| 2019 Q3 | 912.28 Million CNY | 16.87% |
| 2019 Q4 | 894.59 Million CNY | -1.94% |
| 2018 Q2 | 557.66 Million CNY | -12.54% |
| 2018 Q3 | 591.04 Million CNY | 5.99% |
| 2018 Q4 | 527.74 Million CNY | -10.71% |
| 2018 FY | 527.74 Million CNY | -6.65% |
| 2018 Q1 | 637.63 Million CNY | 12.79% |
| 2017 Q1 | 670.7 Million CNY | 18.17% |
| 2017 Q4 | 565.33 Million CNY | -19.94% |
| 2017 Q3 | 706.12 Million CNY | 3.85% |
| 2017 Q2 | 679.96 Million CNY | 1.38% |
| 2017 FY | 565.33 Million CNY | -0.39% |
| 2016 Q1 | 347.63 Million CNY | -9.7% |
| 2016 Q2 | 441.58 Million CNY | 27.02% |
| 2016 Q3 | 454 Million CNY | 2.81% |
| 2016 Q4 | 567.56 Million CNY | 25.01% |
| 2016 FY | 567.56 Million CNY | 47.43% |
| 2015 FY | 384.97 Million CNY | 50.62% |
| 2015 Q3 | 338.29 Million CNY | -10.24% |
| 2015 Q2 | 376.88 Million CNY | 20.77% |
| 2015 Q1 | 312.07 Million CNY | 22.1% |
| 2015 Q4 | 384.97 Million CNY | 13.8% |
| 2014 Q3 | 312.49 Million CNY | 10.1% |
| 2014 Q1 | 278.93 Million CNY | 52.07% |
| 2014 FY | 255.59 Million CNY | 39.35% |
| 2014 Q4 | 255.59 Million CNY | -18.21% |
| 2014 Q2 | 283.82 Million CNY | 1.75% |
| 2013 Q3 | 263.82 Million CNY | -40.56% |
| 2013 Q2 | 443.82 Million CNY | 1389.91% |
| 2013 Q1 | 29.78 Million CNY | 22.56% |
| 2013 Q4 | 183.42 Million CNY | -30.48% |
| 2013 FY | 183.42 Million CNY | 654.66% |
| 2012 FY | 24.3 Million CNY | -23.02% |
| 2012 Q4 | 24.3 Million CNY | 1.4% |
| 2012 Q3 | 23.96 Million CNY | -16.19% |
| 2012 Q2 | 28.6 Million CNY | 19.57% |
| 2012 Q1 | 23.91 Million CNY | -24.24% |
| 2011 Q3 | 40.04 Million CNY | 8.27% |
| 2011 Q2 | 36.98 Million CNY | -20.05% |
| 2011 Q1 | 46.25 Million CNY | 62.41% |
| 2011 FY | 31.57 Million CNY | 10.85% |
| 2011 Q4 | 31.57 Million CNY | -21.16% |
| 2010 Q1 | 58.13 Million CNY | -4.08% |
| 2010 FY | 28.48 Million CNY | -53.01% |
| 2010 Q2 | 64.46 Million CNY | 10.88% |
| 2010 Q4 | 28.48 Million CNY | -51.7% |
| 2010 Q3 | 58.96 Million CNY | -8.52% |
| 2009 FY | 60.61 Million CNY | 14.26% |
| 2009 Q3 | 47.44 Million CNY | 31.06% |
| 2009 Q1 | 50.35 Million CNY | -5.08% |
| 2009 Q4 | 60.61 Million CNY | 27.75% |
| 2009 Q2 | 36.2 Million CNY | -28.1% |
| 2008 Q3 | 71.37 Million CNY | -19.44% |
| 2008 Q4 | 53.04 Million CNY | -25.68% |
| 2008 Q1 | 85.58 Million CNY | -5.15% |
| 2008 Q2 | 88.59 Million CNY | 3.52% |
| 2008 FY | 53.04 Million CNY | -41.21% |
| 2007 Q2 | 110.3 Million CNY | 33.16% |
| 2007 Q4 | 90.22 Million CNY | -2.68% |
| 2007 FY | 90.22 Million CNY | -14.22% |
| 2007 Q1 | 82.83 Million CNY | -21.25% |
| 2007 Q3 | 92.71 Million CNY | -15.95% |
| 2006 FY | 105.18 Million CNY | -4.09% |
| 2006 Q4 | 105.18 Million CNY | -14.56% |
| 2006 Q2 | 127.7 Million CNY | 0.88% |
| 2006 Q3 | 123.12 Million CNY | -3.59% |
| 2006 Q1 | 126.59 Million CNY | 15.43% |
| 2005 Q3 | 158.78 Million CNY | 2.2% |
| 2005 FY | 109.67 Million CNY | -40.71% |
| 2005 Q4 | 109.67 Million CNY | -30.93% |
| 2005 Q2 | 155.36 Million CNY | -10.27% |
| 2005 Q1 | 173.14 Million CNY | -6.4% |
| 2004 FY | 184.98 Million CNY | 32.17% |
| 2004 Q4 | 184.98 Million CNY | 41.25% |
| 2004 Q2 | 143.24 Million CNY | -24.5% |
| 2004 Q1 | 189.74 Million CNY | 35.57% |
| 2004 Q3 | 130.96 Million CNY | -8.57% |
| 2003 Q4 | 139.95 Million CNY | 0.86% |
| 2003 Q1 | 136.82 Million CNY | -4.57% |
| 2003 Q2 | 137.21 Million CNY | 0.29% |
| 2003 FY | 139.95 Million CNY | -2.39% |
| 2003 Q3 | 138.75 Million CNY | 1.12% |
| 2002 Q4 | 143.37 Million CNY | 7.96% |
| 2002 FY | 143.37 Million CNY | -8.76% |
| 2002 Q1 | 156.51 Million CNY | -0.4% |
| 2002 Q2 | 128.11 Million CNY | -18.15% |
| 2002 Q3 | 132.81 Million CNY | 3.67% |
| 2001 Q2 | 179.38 Million CNY | 0.0% |
| 2001 FY | 157.14 Million CNY | -7.0% |
| 2001 Q4 | 157.14 Million CNY | 0.0% |
| 2000 Q4 | 168.97 Million CNY | 0.0% |
| 2000 FY | 168.97 Million CNY | 13.06% |
| 2000 Q2 | 107.81 Million CNY | 0.0% |
| 1999 Q4 | 149.45 Million CNY | 0.0% |
| 1999 Q2 | 146.21 Million CNY | 0.0% |
| 1999 FY | 149.45 Million CNY | -61.11% |
| 1998 FY | 384.28 Million CNY | 80.69% |
| 1998 Q4 | 384.28 Million CNY | 0.0% |
| 1998 Q2 | 211.72 Million CNY | 0.0% |
| 1997 Q4 | 212.67 Million CNY | 0.0% |
| 1997 FY | 212.67 Million CNY | 26.19% |
| 1997 Q2 | 169.36 Million CNY | 0.0% |
| 1996 FY | 168.53 Million CNY | -0.56% |
| 1996 Q2 | 189.3 Million CNY | 0.0% |
| 1996 Q4 | 168.53 Million CNY | 0.0% |
| 1995 Q4 | 169.48 Million CNY | 0.0% |
| 1995 FY | 169.48 Million CNY | 7.14% |
| 1995 Q2 | 158.99 Million CNY | 0.0% |
| 1994 FY | 158.18 Million CNY | 51.64% |
| 1994 Q2 | 136.55 Million CNY | 0.0% |
| 1994 Q4 | 158.18 Million CNY | 0.0% |
| 1993 Q2 | 89.45 Million CNY | 0.0% |
| 1993 FY | 104.31 Million CNY | 23.97% |
| 1993 Q4 | 104.31 Million CNY | 0.0% |
| 1992 FY | 84.14 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 2.75 Billion CNY | 67.744% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.14 Billion CNY | 71.756% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.88 Billion CNY | 77.177% |
| Aurora Optoelectronics Co.,Ltd. | 1.09 Billion CNY | 19.303% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 290.34 Million CNY | -205.679% |
| NanJing Pharmaceutical Company Limited | 20.95 Billion CNY | 95.765% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.12 Billion CNY | 20.797% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 527.57 Million CNY | -68.225% |